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The title compound, C11H11NO3, a condensation product of l-
alanine and ortho-phthalaldehyde, crystallizes in space group
P212121. Intermolecular OÐH  O C and CÐH  O
hydrogen bonds are present with O  O and C  O distances
of 2.623 (3) and 3.338 (4) AÊ , respectively.
Comment
The study of biologically active molecules is of primary
importance in medicinal chemistry. Processes such as hormone
processing, viral replication and cancer cell invasion are
critically dependent on protease enzymes which have recently
become attractive target molecules in drug design (Testa et al.,
1993). Many inhibitors are based on modi®ed amino acids
which incorporate the basic structural features determining
normal enzyme-substrate interactions. Phthalimidine (isoin-
dolin-1-one) derivatives often display biological activity as
potential anti-in¯ammatory agents and antipsychotics (Allin et
al., 1996). The majority of structurally determined phthalimi-
dine systems are either N-substituted or have a hydroxy
substituent at the 3-position (McNab et al., 1997). The title
compound (I), synthesized from l-alanine, is part of an
ongoing study of hydrogen-bonding interactions in phthali-
midine derivatives (Dalton et al., 1999; Gallagher et al., 2000;
Gallagher & Murphy, 1999; Gallagher & Brady, 2000; Brady &
Gallagher, 2001).
A view of the molecule of (I) (S con®guration) with the
atomic numbering scheme is given in Fig. 1 and selected
dimensions are in Table 1. The bond lengths and angles in the
heterocyclic ring are similar to those reported previously
(McNab et al., 1997) and are in agreement with expected
values (Orpen et al., 1994). The angle between the ®ve- and
six-membered rings of the isoindole system is 1.21 (18) and
the maximum deviation from planarity for an atom in either
ring plane is 0.0125 (16) AÊ for N1, while the carbonyl atom O3
is 0.066 (4) AÊ from the C4N ring plane. The ®ve-membered
ring is oriented at an angle of 71.72 (9) to the CCO2
carboxylic acid plane. Examination of (I) with PLATON
(Spek, 1998) revealed no voids in the crystal lattice.
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The hydrogen-bonding in (I) is dominated by an OÐH  O
and a CÐH  O interaction in a two-dimensional network
(Table 2). Conventional carboxylic acid OÐH  O hydrogen
bonding between pairs of carboxylic acid groups with graph
set R22(8) (Ferguson et al., 1995) is not observed in (I), mainly
due to symmetry constraints; instead, the (acid)OÐ
H  O C(phth) interaction generates a one-dimensional
zigzag chain of molecules along the b axis, and these chains are
further linked by the CÐH  O C(acid) interactions along
the a axis.
The crystal structure of (I) contrasts with that of compound
(II), (2R/2S)-2-(1-oxo-1,3-dihydro-2H-isoindol-2-yl)-3-
phenylpropanoic acid (Brady et al., 1998), in which the extra
phenyl group facilitates two CÐH  (arene) interactions.
Molecule (I) is similar, however, to a valine derivative, (2S)-3-
methyl-2-(1-oxo-1H-2,3-dihydroisoindol-2-yl)butanoic acid, in
which the ®ve-membered isoindolyl ring carbonyl C O is
oriented transoid to the H at the chiral centre C2 (Gallagher &
Brady, 2000).
The presence of CÐH  O interactions together with
stronger hydrogen bonds, e.g. OÐH  O, has been
commented on previously (Steiner, 1997). Further studies are
in progress on interactions in related phthalimidine deriva-
tives for application as medicinal drugs.
Experimental
The title compound was prepared by the overnight reaction of l-
alanine and o-phthalaldehyde in re¯uxing CH3CN under N2 (Allin et
al., 1996). Filtration of the hot solution and subsequent slow cooling
of the ®ltrate allowed the isolation of needle-like colourless crystals.
IR, (C O cm
ÿ1), 1730, 1644 (KBr). Melting point 485±487 K
(uncorrected).
Crystal data
C11H11NO3
Mr = 205.21
Orthorhombic, P212121
a = 5.1787 (5) AÊ
b = 9.9128 (18) AÊ
c = 18.918 (5) AÊ
V = 971.2 (3) AÊ 3
Z = 4
Dx = 1.403 Mg m
ÿ3
Mo K radiation
Cell parameters from 25
re¯ections
 = 9.0±18.9
 = 0.10 mmÿ1
T = 294 (1) K
Plate, colourless
0.42  0.21  0.04 mm
Data collection
Enraf±Nonius CAD-4
diffractometer
!±2 scans
Absorption correction: none
1803 measured re¯ections
1086 independent re¯ections
866 re¯ections with I > 2(I)
Rint = 0.024
max = 25.4

h = ÿ6 ! 6
k = ÿ11 ! 11
l = ÿ22 ! 22
3 standard re¯ections
frequency: 240 min
intensity decay: 0.5%
Re®nement
Re®nement on F 2
R[F 2 > 2(F 2)] = 0.039
wR(F 2) = 0.087
S = 1.02
1086 re¯ections
139 parameters
H-atom parameters constrained
w = 1/[2(Fo
2) + (0.0513P)2]
where P = (Fo
2 + 2Fc
2)/3
(/)max < 0.001
max = 0.15 e AÊ
ÿ3
min = ÿ0.14 e AÊ ÿ3
Extinction correction: SHELXL97
Extinction coef®cient: 0.012 (3)
Table 1
Selected geometric parameters (AÊ , ).
O1ÐC1 1.324 (3)
O2ÐC1 1.197 (3)
O3ÐC3 1.235 (3)
N1ÐC2 1.453 (3)
N1ÐC3 1.342 (3)
N1ÐC10 1.455 (3)
C1ÐC2 1.528 (4)
C2ÐC11 1.512 (4)
C3ÐC4 1.479 (4)
C4ÐC9 1.385 (4)
C9ÐC10 1.493 (4)
C2ÐN1ÐC3 122.6 (2)
C2ÐN1ÐC10 123.1 (2)
C3ÐN1ÐC10 112.9 (2)
O1ÐC1ÐO2 123.9 (3)
O1ÐC1ÐC2 112.5 (2)
O2ÐC1ÐC2 123.5 (2)
N1ÐC2ÐC1 107.8 (2)
N1ÐC2ÐC11 113.1 (2)
C1ÐC2ÐC11 115.2 (2)
O3ÐC3ÐN1 124.7 (2)
O3ÐC3ÐC4 128.0 (2)
N1ÐC3ÐC4 107.3 (2)
C3ÐC4ÐC5 130.0 (3)
C8ÐC9ÐC10 130.9 (3)
C3ÐN1ÐC2ÐC1 58.3 (3)
O2ÐC1ÐC2ÐN1 25.0 (4)
O2ÐC1ÐC2ÐC11 152.4 (3)
C2ÐN1ÐC3ÐO3 9.6 (4)
Figure 2
A view of the interactions in the crystal structure.
Figure 1
A view of (I) with the atomic numbering scheme. Displacement ellipsoids
are drawn at the 30% probability level.
electronic reprint
Table 2
Hydrogen-bonding geometry (AÊ , ).
DÐH  A DÐH H  A D  A DÐH  A
O1ÐH1  O3i 0.82 1.80 2.623 (3) 178
C2ÐH2  O2ii 0.98 2.51 3.338 (4) 142
C11ÐH11C  O3 0.96 2.58 3.135 (4) 117
Symmetry codes: (i) ÿx; 12  y; 32 ÿ z; (ii) 1 x; y; z.
Compound (I) crystallized in the orthorhombic system, space
group P212121 from the systematic absences. A full Friedel dataset
was collected for this structure although the anomalous dispersion
terms for O, N and C are small. The absolute con®guration was not
determined [Flack (1983) parameter = 1 (2)] by our X-ray analysis,
but can be inferred from the known absolute con®guration of the l-
alanine starting material used in the synthesis. Friedel pairs were
averaged in the ®nal stages of re®nement. H atoms were treated as
riding atoms using the SHELXL97 defaults with CÐH 0.93 to 0.98 AÊ ,
OÐH 0.82 AÊ .
Data collection: CAD4 (Enraf±Nonius, 1992); cell re®nement:
SET4 and CELDIM (Enraf±Nonius, 1992); data reduction: DATRD2
in NRCVAX96 (Gabe et al., 1989); program(s) used to solve struc-
ture: SHELXS97 (Sheldrick, 1997); program(s) used to re®ne struc-
ture: NRCVAX96 and SHELXL97 (Sheldrick, 1997); molecular
graphics: NRCVAX96, ORTEPII (Johnson, 1976), PLATON (Spek,
1998); software used to prepare material for publication:
NRCVAX96, SHELXL97 and WordPerfect macro PREP8
(Ferguson, 1998).
JFG thanks Dublin City University and Enterprise Ireland
for funding of a research visit to the University of Guelph,
Canada (July±August, 1998) and especially Professor George
Ferguson for use of his diffractometer and computer system
for the collection of the compound (I) dataset.
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